celecoxib has been researched along with quercetin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cha, JY; Eun, KJ; Kim, YH; Lee, YM; Luyen, BT; Tai, BH; Thao, NP; Xin, MJ | 1 |
| Ali, WAM; Bazgier, V; Lamie, PF; Rárová, L | 1 |
| Aldib, I; Chikh Alard, I; De Carvalho, A; Dufrasne, F; Flemmig, J; Furtmüller, PG; Gelbcke, M; Mathieu, V; Meyer, F; Nève, J; Obinger, C; Prévost, M; Rousseau, A; Soubhye, J; Tadrent, S; Van Antwerpen, P; Zouaoui Boudjeltia, K | 1 |
| Alaaeddine, R; Belal, ASF; Bruning, JB; Chua, BSK; El-Yazbi, AF; Elzahhar, PA; Frkic, RL; Ibrahim, TM; Ismail, A; Knape, T; Labib, H; Nassra, R; von Knethen, A; Wallner, N | 1 |
| Kmoníčková, E; Peterková, L; Rimpelová, S; Ruml, T | 1 |
| Abdel-Moty, SG; Abou-Ghadir, OMF; Ali, AY; Maghraby, MT; Salem, OIA | 1 |
| Abd El Wahab, SM; Alaaeddine, R; Allam, RM; Angeli, A; Belal, ASF; Daabees, H; Eid, AH; El-Hawash, SA; El-Yazbi, AF; Elagawany, M; Elzahhar, PA; Hegazy, RR; Helmy, MW; Supuran, CT | 1 |
| Ambadapadi, S; James, MO; Palii, SP; Wang, PL | 1 |
| Chen, J; Jing, H; Liu, X; Luo, L; Qin, T; Shen, Z; Wang, L; Wu, H; Xiong, L; Yang, N; Zhu, X | 1 |
1 review(s) available for celecoxib and quercetin
| Article | Year |
|---|---|
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
Topics: Animals; Antineoplastic Agents; Enzyme Inhibitors; Gene Regulatory Networks; Humans; Neoplasms; Protein Structure, Secondary; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2020 |
12 other study(ies) available for celecoxib and quercetin
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Anti-inflammatory components of Euphorbia humifusa Willd.
Topics: Adamantane; Animals; Anti-Inflammatory Agents; Cell Line; Enzyme Activation; Euphorbia; Inhibitory Concentration 50; Lauric Acids; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Plant Extracts; Tumor Necrosis Factor-alpha | 2014 |
Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Arachidonate 5-Lipoxygenase; Catalytic Domain; Cell Line, Tumor; Chemistry Techniques, Synthetic; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Design; Humans; Indoles; Lipoxygenase Inhibitors; Molecular Docking Simulation; Schiff Bases | 2016 |
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
Topics: Benzimidazoles; Cell Line; Databases, Chemical; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glutamic Acid; Glutamine; Guanidines; Humans; Hydrogen Peroxide; Kinetics; Lactoperoxidase; Lipoproteins, LDL; Models, Chemical; Molecular Docking Simulation; Neutrophils; Oxidation-Reduction; Peroxidase; Quinazolines; Stereoisomerism | 2017 |
Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones.
Topics: Animals; Anti-Inflammatory Agents; Arachidonate 15-Lipoxygenase; Cyclooxygenase 2 Inhibitors; Drug Design; Humans; Ligands; Molecular Docking Simulation; PPAR gamma; Protein Binding; Thiazolidinediones | 2019 |
Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
Topics: Animals; Anti-Inflammatory Agents; Arachidonate 15-Lipoxygenase; Benzimidazoles; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Design; Edema; Lipoxygenase Inhibitors; Male; Molecular Structure; Rats; Structure-Activity Relationship; Thiazoles | 2020 |
Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases.
Topics: Antineoplastic Agents; Arachidonate 15-Lipoxygenase; Carbonic Anhydrases; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship; Triazoles | 2020 |
Celecoxib affects estrogen sulfonation catalyzed by several human hepatic sulfotransferases, but does not stimulate 17-sulfonation in rat liver.
Topics: Adult; Animals; Arylsulfotransferase; Celecoxib; Estradiol; Estrone; Female; Gene Expression; Hepatocytes; Humans; Isoenzymes; Liver; Male; Models, Molecular; Molecular Docking Simulation; Nitrophenols; Primary Cell Culture; Quercetin; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Species Specificity; Structural Homology, Protein; Sulfates; Sulfotransferases; Triclosan | 2017 |
Quercetin Downregulates Cyclooxygenase-2 Expression and HIF-1
Topics: Angiogenesis Inhibitors; Animals; Aortic Aneurysm, Abdominal; Celecoxib; Cyclooxygenase 2 Inhibitors; Dinoprostone; Disease Models, Animal; Down-Regulation; Gene Expression; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Quercetin; Signal Transduction; Vascular Endothelial Growth Factor A | 2020 |